[Adverse effects of biologic agents in treatment of rheumatoid arthritis--prevention of tuberculosis]

Nihon Rinsho. 2005 Jan:63 Suppl 1:573-8.
[Article in Japanese]
No abstract available

Publication types

  • Review

MeSH terms

  • Adalimumab
  • Antibodies, Monoclonal / adverse effects*
  • Antibodies, Monoclonal / therapeutic use
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / adverse effects*
  • Antirheumatic Agents / therapeutic use
  • Antitubercular Agents / administration & dosage*
  • Arthritis, Rheumatoid / drug therapy*
  • Arthritis, Rheumatoid / immunology
  • Etanercept
  • Humans
  • Immunity, Cellular
  • Immunoglobulin G / adverse effects*
  • Immunoglobulin G / therapeutic use
  • Infliximab
  • Isoniazid / administration & dosage*
  • Receptors, Tumor Necrosis Factor / therapeutic use
  • Tuberculosis / diagnosis
  • Tuberculosis / epidemiology
  • Tuberculosis / etiology*
  • Tuberculosis / prevention & control*
  • Tumor Necrosis Factor-alpha / physiology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Antitubercular Agents
  • Immunoglobulin G
  • Receptors, Tumor Necrosis Factor
  • Tumor Necrosis Factor-alpha
  • Infliximab
  • Adalimumab
  • Etanercept
  • Isoniazid